Richard Perrin
Overview
Explore the profile of Richard Perrin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sewell K, Doecke J, Xiong C, Benzinger T, Masters C, Laske C, et al.
Alzheimers Dement
. 2024 Sep;
20(11):7923-7939.
PMID: 39324510
Introduction: We investigated longitudinal associations between self-reported exercise and Alzheimer's disease (AD)-related biomarkers in individuals with autosomal dominant AD (ADAD) mutations. Methods: Participants were 308 ADAD mutation carriers aged 39.7 ...
2.
McDade E, Liu H, Bui Q, Hassenstab J, Gordon B, Benzinger T, et al.
Res Sq
. 2024 Aug;
PMID: 39108475
This study explored the role of the ubiquitin-proteasome system (UPS) in dominantly inherited Alzheimer's disease (DIAD) by examining changes in cerebrospinal fluid (CSF) levels of UPS proteins along with disease...
3.
Rahmani M, Dierker D, Yaeger L, Saykin A, Luckett P, Vlassenko A, et al.
Brain Imaging Behav
. 2024 Jul;
18(5):1310-1322.
PMID: 39083144
This systematic review examines the prevalence, underlying mechanisms, cohort characteristics, evaluation criteria, and cohort types in white matter hyperintensity (WMH) pipeline and implementation literature spanning the last two decades. Following...
4.
Cruchaga C, Bradley J, Western D, Wang C, Lucio Da Fonseca E, Neupane A, et al.
Res Sq
. 2024 Jun;
PMID: 38883718
Alzheimer Disease (AD) is a highly polygenic disease that presents with relatively earlier onset (≤70yo; EOAD) in about 5% of cases. Around 90% of these EOAD cases remain unexplained by...
5.
Cruchaga C, Western D, Timsina J, Wang L, Wang C, Yang C, et al.
Res Sq
. 2023 Jun;
PMID: 37333337
The integration of quantitative trait loci (QTL) with disease genome-wide association studies (GWAS) has proven successful at prioritizing candidate genes at disease-associated loci. QTL mapping has mainly been focused on...
6.
Wang C, Western D, Yang C, Ali M, Wang L, Gorijala P, et al.
Res Sq
. 2023 Jun;
PMID: 37333177
Brain metabolism perturbation can contribute to traits and diseases. We conducted the first large-scale CSF and brain genome-wide association studies, which identified 219 independent associations (59.8% novel) for 144 CSF...
7.
Chatterjee P, Vermunt L, Gordon B, Pedrini S, Boonkamp L, Armstrong N, et al.
Alzheimers Dement
. 2022 Dec;
19(7):2790-2804.
PMID: 36576155
Background: Glial fibrillary acidic protein (GFAP) is a promising candidate blood-based biomarker for Alzheimer's disease (AD) diagnosis and prognostication. The timing of its disease-associated changes, its clinical correlates, and biofluid-type...
8.
Drieu A, Du S, Storck S, Rustenhoven J, Papadopoulos Z, Dykstra T, et al.
Nature
. 2022 Nov;
611(7936):585-593.
PMID: 36352225
Macrophages are important players in the maintenance of tissue homeostasis. Perivascular and leptomeningeal macrophages reside near the central nervous system (CNS) parenchyma, and their role in CNS physiology has not...
9.
Ewers M, Luan Y, Frontzkowski L, Neitzel J, Rubinski A, Dichgans M, et al.
Brain
. 2021 Mar;
144(7):2176-2185.
PMID: 33725114
Cognitive resilience is an important modulating factor of cognitive decline in Alzheimer's disease, but the functional brain mechanisms that support cognitive resilience remain elusive. Given previous findings in normal ageing,...
10.
Walker J, Richardson T, Farrell K, Iida M, Foong C, Shang P, et al.
J Neuropathol Exp Neurol
. 2020 Dec;
80(2):102-111.
PMID: 33367843
Primary age-related tauopathy (PART) is a neurodegenerative entity defined as Alzheimer-type neurofibrillary degeneration primarily affecting the medial temporal lobe with minimal to absent amyloid-β (Aβ) plaque deposition. The extent to...